000 01285 a2200409 4500
005 20250515113648.0
264 0 _c20081010
008 200810s 0 0 chi d
022 _a0529-567X
040 _aNLM
_beng
_cNLM
100 1 _aDong, Li
245 0 0 _a[Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
_h[electronic resource]
260 _bZhonghua fu chan ke za zhi
_cJan 2008
300 _a5-8 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAdult
650 0 4 _aAntigens, Neoplasm
_xblood
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aCA-125 Antigen
_xblood
650 0 4 _aCA-19-9 Antigen
_xblood
650 0 4 _aCystadenoma, Mucinous
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aOvarian Neoplasms
_xblood
650 0 4 _aROC Curve
650 0 4 _aRetrospective Studies
650 0 4 _aSensitivity and Specificity
650 0 4 _aSurvival Analysis
700 1 _aCui, Heng
700 1 _aLi, Xiao-ping
700 1 _aSun, Li-fang
700 1 _aChang, Xiao-hong
700 1 _aLiang, Xu-dong
700 1 _aZhu, Hong-lan
773 0 _tZhonghua fu chan ke za zhi
_gvol. 43
_gno. 1
_gp. 5-8
999 _c17867238
_d17867238